Search
Syncephalastrum racemosum
go.drugbank.com/drugs/DB10848ApprovedSyncephalastrum racemosum is a fungus which can provoke allergic reactions. Syncephalastrum racemosum extract is used in allergenic testing.
Epidermophyton floccosum
go.drugbank.com/drugs/DB10870ApprovedEpidermophyton floccosum is a fungus which can provoke allergic reactions. Epidermophyton floccosum extract is used in allergenic testing.
Pleospora betae
go.drugbank.com/drugs/DB10936ApprovedPleospora betae is a fungus which can provoke allergic reactions. Pleospora betae extract is used in allergenic testing.
Trichophyton tonsurans
go.drugbank.com/drugs/DB10970ApprovedTrichophyton tonsurans is a fungus which can provoke allergic reactions. Trichophyton tonsurans extract is used in allergenic testing.
Trichophyton verrucosum
go.drugbank.com/drugs/DB11295ApprovedTrichophyton verrucosum is a fungus which can provoke allergic reactions. Trichophyton verrucosum extract is used in allergenic testing.
BIIB015
go.drugbank.com/drugs/DB06304InvestigationalBIIB015 is a humanized, IgG1 [immunoglobulin G 1], DM4-Conjugated, anti-cripto, monoclonal antibody. It has been investigated for the treatment of subjects with relapsed or refractory solid tumours.
Navitoclax
go.drugbank.com/drugs/DB12340InvestigationalNavitoclax is an orally bioavailable small molecule inhibitor of Bcl-2 family proteins. It is a substance being studied in the treatment of lymphomas and other types of cancer. … Navitoclax has been used in trials studying the treatment and basic science of Solid Tumors, Non-Hodgkin's Lymphoma, EGFR Activating Mutation, Chronic Lymphoid Leukemia, and Hematological Malignancies,
Synonyms: (R)-4-(3-Morpholin-4-Yl-1-Phenylsulfanylmethyl-Propylamino)-N-(4-{4-[2-(4-Chlorophenyl)-5,5-Dimethylcyclohex-1-Enylmethyl]-Piperazin-1-Yl}-Benzoyl)-3-TrifluoromethanesulfonylbenzenesulfonamideIC41
go.drugbank.com/drugs/DB05776InvestigationalIC41 is a therapeutic peptide vaccine. It is being devloped by Intercell AG for the treatment of hepatitis C.
αAβ–Gas6
go.drugbank.com/drugs/DB17069Experimentalfor receptor kinases expressed in glial cells. … αAβ–Gas6 is a chimeric fusion protein being investigated in preclinical studies as an immunotherapeutic agent for Alzheimer's disease (AD).
Parethoxycaine
go.drugbank.com/drugs/DB19380ApprovedWithdrawnParethoxycaine is a local anesthetic that was previously approved in the US.